AzTrials
AzTrials

Foreign Body Airway ObstructionNCT07348848

Prospective Evaluation of Foreign Body Airway Obstruction Interventions Among Infants

An observational study of Foreign Body Airway Obstruction, run by University of Calgary at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Foreign body airway obstruction (FBAO, choking) is a life-threatening emergency requiring time-sensitive treatment to prevent severe injury or deaths. Traditional treatments taught in first aid courses include abdominal thrusts, back blows, and chest compressions or thrusts. Read more about this study

Who is it for?
Ages Up to 2 years
Conditions the study is for
Foreign Body Airway Obstruction
What is being tested?
Chest compressions/thrusts, Back blows and Abdominal Thrusts
Type of treatment
Surgery or procedure
How many people
39 participants
Where
1 siteCanada
Study dates
1 Nov 2025to 30 Jun 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 2 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Infants (aged 2 years or less) who experienced an out-of-hospital FBAO and received a FBAO intervention while conscious in Alberta, Canada, and, subsequently, were assessed by EMS or at an emergency department

Who may be able to join

  • Infants (aged 2 years or less) who experienced an out-of-hospital FBAO in Alberta, Canada
  • Received a FBAO intervention while conscious by bystander or healthcare provider
  • Were assessed by EMS at the time of the incident, or later attended an emergency department due to the incident

Who cannot join

  • Patients with abnormal airway anatomy such as a tracheostomy.
  • Patients who were unconscious when they received the initial FBAO intervention

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Virtual

    Calgary, Alberta

Other trials in Canada

About this study

Official title: Prospective Evaluation of Foreign Body Airway Obstruction Interventions Among Infants: A Non-randomized Pilot Cohort Study

Foreign body airway obstruction (FBAO, choking) is a life-threatening emergency requiring time-sensitive treatment to prevent severe injury or deaths. Traditional treatments taught in first aid courses include abdominal thrusts, back blows, and chest compressions or thrusts. Currently, first aid guidelines recommend different treatments for adults, child and infants.

Until recently, data on these techniques was limited to case series from the late 1900's. To further improve our knowledge of which treatment is most effective and safest for patients, this study will collect data on choking incidents in Alberta, Canada. The first phase of this project will make sure identifying and recruiting choking patients in real-time is possible so that the highest quality of data can be collected. If successful, this study will support a future project where the different choking treatments are compared in terms of their effectiveness and safety. This study will focus on infants aged 2 years or younger.

Being tested
Chest compressions/thrusts, Back blows, Abdominal Thrusts
Keywords
Choking, Infants, Prospective cohort, Feasibility
Medical subject headings
Airway Obstruction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Chest compressions/thrustsProcedure or surgery

    Chest compressions or thrusts received as first intervention

  • Back blowsProcedure or surgery

    Back blows received as first intervention

  • Abdominal ThrustsProcedure or surgery

    Abdominal thrusts received as first intervention

Study groups in NCT07348848
Study groupRoleWhat they receive
Infants with FBAOInfants (aged 2 years or younger) with a foreign body airway obstruction who are conscious when they receive their first intervention
Receives: Procedure: Chest compressions/thrusts; Procedure: Back blows; Procedure: Abdominal Thrusts

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Eligible patient recruitment

    Count of eligible patients recruited per month

    Measured: Through study completion, a 6 month period

Secondary outcomes (6)
  1. Proportion of eligible patients recruited

    Among patients who screen as eligible for recruitment, the proportion of those who are successfully recruited

    Measured: Through study completion, a 6 month period

  2. Proportion of recruited patients with satisfactory data collection

    Among patients successfully recruited, the those patients with >= 90% of desired variables collected

    Measured: Through study completion, a 6 month period

  3. Foreign body airway obstruction relief

    Defined as: responders determining that the patient did not require further FBAO intervention due to improvement or resolution of their respiratory distress in a conscious patient, or the ability for a responder to successfully ventilate an unconscious patient when previously they were unable to due to obstruction

    Measured: Day 1

  4. Survival to acute care discharge

    Defined as discharge from the care of Emergency Medical Services(EMS) or paramedics, the emergency department, or the hospital.

    Measured: From date of enrolment until the date of acute care discharge or date of death from any cause, whichever came first, assessed up to 3 month

  5. Survival to acute care discharge with favourable neurological outcome

    Defined as the patient being able to be discharge to the home environment that they previously lived, with the ability to perform the same activities of daily living as before the FBAO incident

    Measured: From date of enrolment until the date of acute care discharge or date of death from any cause, whichever came first, assessed up to 3 month

  6. Intervention-associated injuries

    Listed summary of any injuries reported among patient recruited for study occurring as a result of the FBAO intervention as determined by the treating physician/care provider

    Measured: From date of enrolment until the date of acute care discharge or date of death from any cause, whichever came first, assessed up to 3 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jan 2026
  2. Study start1 Nov 2025
  3. Primary completion30 Apr 2026
  4. Study completion30 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
39 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07348848
Sponsor's protocol ID
REB25-0419B
Status last verified
Sep 2026
First submitted
29 Sep 2025
Last updated
9 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Foreign Body Airway Obstruction, run by University of Calgary at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Eligible patient recruitment (time frame: Through study completion, a 6 month period). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in